Akilavalli Narasimhan1, Rafael R Flores1, Christina D Camell1, David A Bernlohr1, Paul D Robbins2, Laura J Niedernhofer2. 1. Institute On the Biology of Aging and Metabolism, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, 6-155 Jackson Hall, 321 Church Street, SE, Minneapolis, MN, 55455, USA. 2. Institute On the Biology of Aging and Metabolism, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, 6-155 Jackson Hall, 321 Church Street, SE, Minneapolis, MN, 55455, USA. lniedern@umn.edu.
Abstract
PURPOSE OF REVIEW: Obesity has increased worldwide recently and represents a major global health challenge. This review focuses on the obesity-associated cellular senescence in various organs and the role of these senescent cells (SnCs) in driving complications associated with obesity. Also, the ability to target SnCs pharmacologically with drugs termed senotherapeutics as a therapy for these complications is discussed. RECENT FINDINGS: Several studies have shown a positive correlation between obesity and SnC burden in organs such as adipose tissue, liver, and pancreatic-β-cells. These SnCs produce several secretory factors which affect other cells and tissues in a paracrine manner resulting in organ dysfunction. The accumulation of SnCs in adipocytes affects their lipid storage and impairs adipogenesis. The inflammatory senescence-associated secretory phenotype (SASP) of SnCs downregulates the antioxidant capacity and mitochondrial function in tissues. Senescent hepatocytes cannot oxidize fatty acids, which leads to lipid deposition and senescence in β-cells decrease function. These and other adverse effects of SnCs contribute to insulin resistance and type-2 diabetes. The reduction in the SnC burden genetically or pharmacologically improves the complications associated with obesity. The accumulation of SnCs with age and disease accelerates aging. Obesity is a key driver of SnC accumulation, and the complications associated with obesity can be controlled by reducing the SnC burden. Thus, senotherapeutic drugs have the potential to be an effective therapeutic option.
PURPOSE OF REVIEW: Obesity has increased worldwide recently and represents a major global health challenge. This review focuses on the obesity-associated cellular senescence in various organs and the role of these senescent cells (SnCs) in driving complications associated with obesity. Also, the ability to target SnCs pharmacologically with drugs termed senotherapeutics as a therapy for these complications is discussed. RECENT FINDINGS: Several studies have shown a positive correlation between obesity and SnC burden in organs such as adipose tissue, liver, and pancreatic-β-cells. These SnCs produce several secretory factors which affect other cells and tissues in a paracrine manner resulting in organ dysfunction. The accumulation of SnCs in adipocytes affects their lipid storage and impairs adipogenesis. The inflammatory senescence-associated secretory phenotype (SASP) of SnCs downregulates the antioxidant capacity and mitochondrial function in tissues. Senescent hepatocytes cannot oxidize fatty acids, which leads to lipid deposition and senescence in β-cells decrease function. These and other adverse effects of SnCs contribute to insulin resistance and type-2 diabetes. The reduction in the SnC burden genetically or pharmacologically improves the complications associated with obesity. The accumulation of SnCs with age and disease accelerates aging. Obesity is a key driver of SnC accumulation, and the complications associated with obesity can be controlled by reducing the SnC burden. Thus, senotherapeutic drugs have the potential to be an effective therapeutic option.
Authors: O S Al-Attas; N Al-Daghri; A Bamakhramah; S Shaun Sabico; P McTernan; T T-K Huang Journal: Acta Paediatr Date: 2010-02-24 Impact factor: 2.299
Authors: Christina A Roberto; Boyd Swinburn; Corinna Hawkes; Terry T-K Huang; Sergio A Costa; Marice Ashe; Lindsey Zwicker; John H Cawley; Kelly D Brownell Journal: Lancet Date: 2015-02-19 Impact factor: 79.321
Authors: Roberto C Licea-Cejudo; Laura K Arenas-Sandoval; Jonathan Salazar-León; Mónica V Martínez-Martínez; Alfonso Carreón-Rodríguez; Gustavo Pedraza-Alva; Leonor Pérez-Martínez Journal: Acta Paediatr Date: 2020-03-12 Impact factor: 2.299
Authors: Diana B P Clemente; Lea Maitre; Mariona Bustamante; Leda Chatzi; Theano Roumeliotaki; Serena Fossati; Regina Grazuleviciene; Kristine B Gützkow; Johanna Lepeule; Dries S Martens; Rosie R C McEachan; Helle M Meltzer; Inga Petraviciene; Rémy Slama; Ibon Tamayo-Uria; Jose Urquiza; Marina Vafeiadi; John Wright; Tim S Nawrot; Martine Vrijheid Journal: Sci Rep Date: 2019-12-10 Impact factor: 4.379